Adverse Drug Reactions in Hospitalized-Geriatric Patients with Hypertension
Abstract
Keywords
Full Text:
PDFReferences
World Health Organization (WHO). WHO Draft Guidelines for Adverse Event Reporting and Learning Systems. Geneva: WHO, 2005.
Schatz SN, Weber RJ. Adverse Drug Reactions (Adverse Drug Effects). Pharmacother Self-Assessment Program. 2015;42(1):12-16.
Beijer HJM, De Blaey CJ. Hospitalisations caused by adverse drug reactions (ADRs): A meta-analysis of observational studies. Pharmacy World and Science. 2002;24(2):46-54.
Pirmohamed M, James S, Meakin S, Green C. Adverse drug reactions as cause of admission to hospital: Authors’ reply. Bmj. 2004;329(7463):460.
Kongkaew C, Noyce PR, Aschcroft DM. Annals of Pharmacotherapy Objective, Findings, Discussion , Conclusions. Annalysis of Pharmacotherapy. 2008;42(7):1017-1025.
Lavan AH, Gallagher P. Predicting risk of adverse drug reactions in older adults. Theapeutic Advance in Drug Safety. 2016;7(1):11-22.
Brooks JO, Hoblyn JC. Secundary mania in older adults. American Journal of Psychiatry. 2005;162:2033-8.
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, Roccella EJ. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. Journal of American Medical Association. 2003;289:2560-2572.
Nawi R, Arsunan A, Jalla K. Analisis Faktor Risiko Kejadian Hipertensi pada Dewasa Muda di Unit Rawat Jalan Rumah Sakit Umum Labuang Baji Makasar. Jurnal Media Kesehatan Masyarakat Indonesia. 2006.
Levy D, Larson MG, Vasan RS, Kannel WB, Ho KK. The progression from hypertension to congestive heart failure. Journal of American Medical Association. 1996;275:1557-1562.
Danan G, Benichou C. Causality assessment of adverse reactions to drugs – I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. Journal of Clinical Epidemiology. 1993;46:1323-1330.
Maria V and Victorino, R. Development and validation of a clinical scale for the diagnosis of druginduced hepatitis. Hepatology. 1997;26:664-669.
World Health Organization. The use of the WHO-UMC system for standardized case causality assessment. World Health Organization, Uppsala Monitoring Centre. 2015.
Naranjo C, Busto U, Sellers E, Sandor P, Ruiz I, Roberts E. A method for estimating the probability of adverse drug reactions. Clinical Pharmacology Therapy. 1981;30:239-245.
DOI: https://doi.org/10.15416/pcpr.v4i3.24923
Refbacks
- There are currently no refbacks.